References
- MichorFHughesTPIwasaYDynamics of chronic myeloid leukaemiaNature200543570461267127015988530
- HuntlyBJGillilandDGCancer biology: summing up cancer stem cellsNature200543570461169117015988505
- PfenningerCVRoschupkinaTHertwigFCD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cellsCancer Res200767125727573617575139
- YiJMTsaiHCGlocknerSCAbnormal DNA methylation of CD133 in colorectal and glioblastoma tumorsCancer Res200868198094810318829568
- MiragliaSGodfreyWYinAHA novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloningBlood19979012501350219389721
- BhatiaMAC133 expression in human stem cellsLeukemia200115111685168811681407
- CorbeilDRoperKHellwigAThe human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusionsJ Biol Chem200027585512552010681530
- RafiiSCirculating endothelial precursors: mystery, reality, and promiseJ Clin Invest20001051171910619857
- SinghSKClarkeIDTerasakiMIdentification of a cancer stem cell in human brain tumorsCancer Res200363185821582814522905
- SinghSKHawkinsCClarkeIDIdentification of human brain tumour initiating cellsNature2004432701539640115549107
- YinSLiJHuCCD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityInt J Cancer200712071444145017205516
- YangKChenXZZhangBIs CD133 a biomarker for cancer stem cells of colorectal cancer and brain tumors? A meta-analysisInt J Biol Markers201126317318021786247
- XiaPSurface markers of cancer stem cells in solid tumorsCurr Stem Cell Res Ther20139210211124359139
- MoghbeliMMoghbeliFForghanifardMMAbbaszadeganMRCancer stem cell detection and isolationMed Oncol20143196925064729
- MaitlandNJCollinsATCancer stem cells – a therapeutic target?Curr Opin Mol Ther201012666267321154158
- AllegraAAlonciAPennaGThe cancer stem cell hypothesis: a guide to potential molecular targetsCancer Invest201432947049525254602
- IslamTJosephsonLCurrent state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticlesCancer Biomark2009529910719414927
- WeisslederRElizondoGWittenbergJRabitoCABengeleHHJosephsonLUltrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imagingRadiology199017524894932326474
- TanimotoAOshioKSuematsuMPouliquenDStarkDDRelaxation effects of clustered particlesJ Magn Reson Imaging2001141727711436217
- GossuinYGillisPHocqAVuongQLRochAMagnetic resonance relaxation properties of superparamagnetic particlesWiley Interdiscip Rev Nanomed Nanobiotechnol20091329931020049798
- HimmelreichUDresselaersTCell labeling and tracking for experimental models using magnetic resonance imagingMethods200948211212419362150
- CorotCRobertPIdeeJMPortMRecent advances in iron oxide nanocrystal technology for medical imagingAdv Drug Deliv Rev200658141471150417116343
- ZhangCJugoldMWoenneECSpecific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scannerCancer Res20076741555156217308094
- BaioGFabbiMde ToteroDMagnetic resonance imaging at 1.5T with immunospecific contrast agent in vitro and in vivo in a xenotransplant modelMAGMA200619631332017160691
- BaioGFabbiMSalviSTwo-step in vivo tumor targeting by biotin-conjugated antibodies and superparamagnetic nanoparticles assessed by magnetic resonance imaging at 1.5 TMol Imaging Biol200912330531519806404
- HuangKWChiehJJLinITHorngHEYangHCHongCYAnti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivoNanoscale Res Lett20138141324103079
- HsiehWJLiangCJChiehJJIn vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticlesInt J Nanomedicine201272833284222745546
- YangLPengXHWangYAReceptor-targeted nanoparticles for in vivo imaging of breast cancerClin Cancer Res200915144722473219584158
- ShamsipourFZarnaniAHGhodsRConjugation of monoclonal antibodies to super paramagnetic iron oxide nanoparticles for detection of her2/neu antigen on breast cancer cell linesAvicenna J Med Biotechnol200911273123407330
- WangXWeiFLiuACancer stem cell labeling using poly(L-lysine)-modified iron oxide nanoparticlesBiomaterials201233143719373222342710
- WongDYChangKWChenCFChangRCCharacterization of two new cell lines derived from oral cavity human squamous cell carcinomas–OC1 and OC2J Oral Maxillofac Surg19904843853902156034
- JiangWYangHCYangSYPreparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatibleJ Magn Magn Mater20042832–3210214
- HorngHEYangSYHuangYWJiangWQHongCYYangHCNanomagnetic particles for SQUID-based magnetically labeled immunoassayIEEE Trans Appl Supercond2005152668671
- YangSYJianZFHorngHEDual immobilization and magnetic manipulation of magnetic nanoparticlesJ Magn Magn Mater20083202126882691
- HuangKWYangSYHorngHETime-evolution contrast of target MRI using high-stability antibody functionalized magnetic nanoparticles: an animal modelJ Nanomater20142014351848
- HongC-YChenWSJianZFWash-free immunomagnetic detection for serum through magnetic susceptibility reductionAppl Phys Lett2007907074105
- YangCCHuangKWYangSYDevelopment for high-accuracy in vitro assay of vascular endothelial growth factor using nanomagnetically labeled immunoassayJ Nanomater20132013695276
- YangCCYangSYHoCSChangJFLiuBHHuangKWDevelopment of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical useJ Nanobiotechnol201412144
- ChenFJLeeKWLaiCCStructure of native oligomeric Sprouty2 by electron microscopy and its property of electroconductivityBiochem Biophys Res Commun2013439335135624012675
- PawelczykEArbabASPanditSHuEFrankJAExpression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imagingNMR Biomed200619558159216673357
- ChenYWTsaiMYPanHBTsengHHHungYTChouCPGadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with sho-saiko-toPLoS One2014912e11475625490034
- StahnRRoseSSanbornSWestGHerschmanHEffects of nerve growth factor administration of N-ethyl-N-nitrosourea carcinogenesisBrain Res19759622872981175013
- HabsMSchmahlDInfluence of five different postnatal lifelong treatments on the transplacental carcinogenicity of ethylnitrosourea in Sprague-Dawley ratsCancer Lett19762293100797445
- IetaKTanakaFHaraguchiNBiological and genetic characteristics of tumor-initiating cells in colon cancerAnn Surg Oncol200815263864817932721
- SharifiSBehzadiSLaurentSForrestMLStroevePMahmoudiMToxicity of nanomaterialsChem Soc Rev20124162323234322170510
- KimJEShinJYChoMHMagnetic nanoparticles: an update of application for drug delivery and possible toxic effectsArch Toxicol201286568570022076106
- RosenblumLTKosakaNMitsunagaMChoykePLKobayashiHIn vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosisMol Membr Biol201027727428520455640
- PengXHQianXMaoHTargeted magnetic iron oxide nanoparticles for tumor imaging and therapyInt J Nanomedicine20083331132118990940
- JiangTZhangCZhengXNoninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scannerInt J Nanomedicine2009424124920011241
- ShevtsovMANikolaevBPYakovlevaLYSuperparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumorsInt J Nanomedicine2014927328724421639
- SunRDittrichJLe-HuuMPhysical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparisonInvest Radiol200540850451316024988
- GuoQLiuYXuKRenKSunWMouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticlesInt J Nanomedicine201382273228423818783
- ChenHWangLYuQAnti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancerInt J Nanomedicine201383781379424124366
- WangXXingXZhangBLiuFChengYShiDSurface engineered antifouling optomagnetic SPIONs for bimodal targeted imaging of pancreatic cancer cellsInt J Nanomedicine201491601161524741308
- MooreAMedarovaZPotthastADaiGIn vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probeCancer Res20046451821182714996745
- SimbergDDuzaTParkJHBiomimetic amplification of nanoparticle homing to tumorsProc Natl Acad Sci U S A2007104393293617215365
- Al FarajAShaikASAfzalSAl SayedBHalwaniRMR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticlesInt J Nanomedicine201491491150324711699
- TownerRASmithNTesiramYAIn vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imagingMol Imaging200761182917311762
- ThorekDLChenAKCzuprynaJTsourkasASuperparamagnetic iron oxide nanoparticle probes for molecular imagingAnn Biomed Eng2006341233816496086
- ArbabASYocumGTRadAMLabeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cellsNMR Biomed200518855355916229060
- WangYXSuperparamagnetic iron oxide based MRI contrast agents: current status of clinical applicationQuant Imaging Med Surg201211354023256052
- SchlachterEKWidmerHRBregyAMetabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo studyInt J Nanomedicine201161793180021980242
- ChertokBDavidAEYangVCBrain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topographyJ Control Release2011155339339921763736
- FleigeGNolteCSynowitzMSeebergerFKettenmannHZimmerCMagnetic labeling of activated microglia in experimental gliomasNeoplasia20013648949911774031
- ProkopADavidsonJMNanovehicular intracellular delivery systemsJ Pharm Sci20089793518359018200527
- WangMThanouMTargeting nanoparticles to cancerPharmacol Res2010622909920380880
- WangYXHussainSMKrestinGPSuperparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imagingEur Radiol200111112319233111702180
- HuangXPengXWangYShinDMEl-SayedMANieSA reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligandsACS Nano20104105887589620863096
- ChertokBMoffatBADavidAEIron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials200829448749617964647
- SunJZhangCLiuGA novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitroClin Exp Metastasis201229318519622228571
- GonzalesNRDe PascalisRSchlomJKashmiriSVMinimizing the immunogenicity of antibodies for clinical applicationTumour Biol2005261314315741769
- JalalianSHTaghdisiSMShahidi HamedaniNEpirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivoEur J Pharm Sci201350219119723835028